2 soaring growth stocks I’d buy for the next 25 years

Many investors steer clear of shares that are already flying, but there shouldn’t be any need to be scared of these two.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

Growth

Image: Public domain

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

GB Group (LSE: GBG) doesn’t exactly have an exciting name, but you could be forgiven for dancing with glee if you’d bought some shares five years ago as you’d be sitting on a four-bagger now.

Earnings per share multiplied 2.6-fold between the years ending March 2013 and 2017, with the shares on consistently low PEG ratings. That kind of growth usually comes at a price, and at 401p the shares are now rated on a forward P/E of 31 for the current year, dropping to 27 next. But I don’t think that’s too stretching.

What does GB Group do? The company bills itself as an identity data intelligence specialist, and its services are used in the growing fight against fraud. That is already big business today, and I can’t see any drop off in demand for this kind of service in the next few decades.

Revenue rise

A trading update Tuesday revealed a 40% rise in revenue in the first half of the year, to £52.6m, which represents organic growth of approximately 17% — including £3.5m from the signing of a perpetual licence with a “leading European bank“.

The firm expects to report a 90% rise in adjusted operating profit, to more than £10m, which is ahead of expectations — and I can see forecasts being upgraded now.

While growth looks good, dividend seekers might be unimpressed by a yield of under 1%. But it’s strongly progressive and rising way faster than inflation, with forecasts suggesting a doubling between 2013 and March 2019. And it’s eight times covered by earnings.

That suggests the potential for a much bigger dividend as this company matures from its early growth phase, and I see a long-term cash cow here.

Faster growth

There’s been an even more impressive gain from CVS Group (LSE: CVSG), whose shares have eight-bagged in the same period, to 1,345p.

The company, which describes itself as “the UK’s leading provider of integrated veterinary services“, is in a perhaps more obviously growing business — more and more people are spending more and more money looking after their domestic animals than ever before, and I really can’t see that declining any time soon.

Again we’re seeing a relatively high forward P/E, of around 29, but again I don’t think that’s too high for a company with this kind of long-term potential. I expect we’ll see some price volatility as CVS gets to maturity and earnings growth slows a little, but by then I think it will be well on its way to providing a good dividend income.

Dividends to come

Dividend yields are currently low at around 0.4%, but we’re looking at around nine-fold cover by earnings — and another progressive policy.

If forecasts come good, by June 2018 investors will have enjoyed a 2.7-fold rise in their annual dividend payment, and I see potential for a lot more than that over the next decade and more.

But right now, that cash looks to be better spent on acquisitions, with July’s update telling us of 62 more surgeries having been bought up at a cost of £47.4m. There’s net debt too, albeit of a quite modest £68m at the interim stage, and that’s a likely target for spare medium-term cash too.

Overall, I see a good bit more growth to come, with another cash cow in the making over the longer term.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Alan Oscroft has no position in any of the shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

2 resurgent cheap shares that could skyrocket in 2025

Cheap shares can take our portfolios to the next level. Here, Dr James Fox highlights two stocks that appear to…

Read more »

Investing Articles

How much does an investor need in a Stocks and Shares ISA to earn £1,000 a month in passive income?

A Stocks and Shares ISA's a valuable asset for investors. Not having to pay dividend tax can be a big…

Read more »

Investing Articles

9% dividend yield! Could buying this FTSE 250 stock earn me massive passive income?

Assura looks like an outstanding stock for dividend investors to consider. But is the 9% dividend yield the passive income…

Read more »

Man putting his card into an ATM machine while his son sits in a stroller beside him.
Investing Articles

Why I think this month could be critical for the Lloyds share price!

Our writer explains why he thinks the bank's 2024 results will have a significant impact on the short-term direction of…

Read more »

British Pennies on a Pound Note
Investing Articles

This former penny share has soared 168%. Is the best yet to come?

When Christopher Ruane saw a penny share as a potential bargain last year, he was spot on. So having not…

Read more »

Mature couple at the beach
Investing Articles

£20k in an ISA? Here’s how it could generate £1 of passive income every hour — forever

With a long-term approach, Christopher Ruane explains how an investor could aim to earn a pound per hour in passive…

Read more »

One English pound placed on a graph to represent an economic down turn
Investing Articles

FTSE shares: overpriced or still a bargain?

Christopher Ruane reckons a storming FTSE 100 performance of late doesn't tell us much about whether there are still possible…

Read more »

Blue NIO sports car in Oslo showroom
Investing Articles

Would an investor have made money investing £2k in NIO stock 5 years ago?

Our writer looks at how NIO stock has performed over recent years and weighs the bull and bear cases as…

Read more »